Osteoporosis Research Today is a free monthly online journal that collates and summarizes the latest research about Osteoporosis, including details on symptoms, treatment, prevention, causes.

Volume 2 (2005), Issue 7 (July)

1. High dose estrogen treatment increases bone mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone.
   Eur J Endocrinol, 153(1): 107-13. [Abstract] [Full-text]
2. Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma.
   Eur J Endocrinol, 153(1): 23-9. [Abstract] [Full-text]
3. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus.
   Arthritis Rheum, 52(7): 2044-50. [Abstract] [Full-text]
4. A comparative study between axial compression and lateral fall configuration tested in a rat proximal femur model.
   Clin Biomech (Bristol, Avon), 20(7): 729-35. [Abstract] [Full-text]
5. Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies.
   QJM, 98(7): 467-84. [Abstract] [Full-text]
6. Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy.
   J Clin Endocrinol Metab, 90(7): 3970-7. [Abstract] [Full-text]
7. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate.
   J Clin Endocrinol Metab, 90(7): 3877-85. [Abstract] [Full-text]
8. Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases.
   J Clin Endocrinol Metab, 90(7): 4394-8. [Abstract] [Full-text]
9. Are we treating women with postmenopausal osteoporosis for their low BMD or high fracture risk?
   J Bone Miner Res, 20(8): 1480-1. [Abstract] [Full-text]
10. Pamidronate prevents bone loss and decreased bone strength in adult female and male rats fed an isocaloric low-protein diet.
    J Bone Miner Res, 20(8): 1365-71. [Abstract] [Full-text]
11. Association of the OSCAR promoter polymorphism with BMD in postmenopausal women.
    J Bone Miner Res, 20(8): 1342-8. [Abstract] [Full-text]
12. Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in hospitalized, elderly women with Alzheimer's disease: a randomized controlled trial.
    J Bone Miner Res, 20(8): 1327-33. [Abstract] [Full-text]
13. Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.
    J Bone Miner Res, 20(8): 1315-22. [Abstract] [Full-text]
14. Emerging concepts in osteoporosis and bone strength.
    Curr Med Res Opin, 21(7): 1049-56. [Abstract] [Full-text]
15. The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis.
    Curr Med Res Opin, 21(7): 1027-34. [Abstract] [Full-text]
16. Clinical use of serum and urine bone markers in the management of osteoporosis.
    Curr Med Res Opin, 21(7): 1015-26. [Abstract] [Full-text]
17. Genistein derivatives as selective estrogen receptor modulators: sonochemical synthesis and in vivo anti-osteoporotic action.
    Bioorg Med Chem, 13(16): 4880-90. [Abstract] [Full-text]
18. Early identification and interventions for female athlete triad.
    J Pediatr Health Care, 19(4): 213-20. [Abstract] [Full-text]
19. A comparison of bone mineral density in oligomenorrhoeic adolescents with polycystic ovaries and normal ovaries.
    Gynecol Endocrinol, 20(5): 237-42. [Abstract] [Full-text]
20. Effect of zinc supplementation on ethanol-mediated bone alterations.
    Food Chem Toxicol, 43(10): 1497-505. [Abstract] [Full-text]
21. Soluble cathepsin K: a novel marker for the prediction of nontraumatic fractures?
    J Lab Clin Med, 146(1): 13-7. [Abstract] [Full-text]
22. Vitamin K in the treatment and prevention of osteoporosis and arterial calcification.
    Am J Health Syst Pharm, 62(15): 1574-81. [Abstract] [Full-text]
23. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
24. Advanced glycation end products and bone loss during aging.
    Ann N Y Acad Sci, 1043: 710-7. [Abstract] [Full-text]
25. Changes in mineralization and biomechanics of tibial metaphyses in splinted rats.
    J Appl Physiol, 99(1): 173-80. [Abstract] [Full-text]
26. Power training is more effective than strength training for maintaining bone mineral density in postmenopausal women.
    J Appl Physiol, 99(1): 181-8. [Abstract] [Full-text]
27. Osteoporosis is associated with increased marrow fat content and decreased marrow fat unsaturation: a proton MR spectroscopy study.
    J Magn Reson Imaging, 22(2): 279-85. [Abstract] [Full-text]
28. Clinical management of osteoporosis in women with a history of breast carcinoma.
    Cancer, 104(3): 443-56. [Abstract] [Full-text]
29. A pilot study of bone density loss in menopausal women treated with chemotherapy for cancer.
    Support Care Cancer, 13(8): 663-7. [Abstract] [Full-text]
30. Prostaglandin EP4 receptor agonist augments fixation of hydroxyapatite-coated implants in a rat model of osteoporosis.
    J Bone Joint Surg Br, 87(8): 1150-6. [Abstract] [Full-text]

© 2004-2008 Osteoporosis Research Today. All Rights Reserved.